Gossamer Bio Other Current Assets (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.52 +0.07 (+2.86%) USD | NASDAQ | Jan 16, 16:00

2.46 -0.06 (-2.38%) Pre-Market: 08:58

View Other Current Assets (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Assets (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	Upgrade
XOMA Royalty Corp.	Upgrade
Rezolute, Inc.	Upgrade
Axsome Therapeutics, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade